JPS603287B2 - Method for isolating and purifying factors that inhibit mutagenicity of mutagenic substances from cabbage use - Google Patents
Method for isolating and purifying factors that inhibit mutagenicity of mutagenic substances from cabbage useInfo
- Publication number
- JPS603287B2 JPS603287B2 JP53028840A JP2884078A JPS603287B2 JP S603287 B2 JPS603287 B2 JP S603287B2 JP 53028840 A JP53028840 A JP 53028840A JP 2884078 A JP2884078 A JP 2884078A JP S603287 B2 JPS603287 B2 JP S603287B2
- Authority
- JP
- Japan
- Prior art keywords
- cellulose
- supernatant
- fraction
- cabbage
- mutagenicity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims description 11
- 230000003505 mutagenic effect Effects 0.000 title claims description 8
- 231100000219 mutagenic Toxicity 0.000 title claims description 7
- 231100000299 mutagenicity Toxicity 0.000 title claims description 4
- 230000007886 mutagenicity Effects 0.000 title claims description 4
- 240000007124 Brassica oleracea Species 0.000 title description 12
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 title description 12
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 title description 12
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 title description 12
- 239000000126 substance Substances 0.000 title description 7
- 229920002678 cellulose Polymers 0.000 claims description 14
- 239000001913 cellulose Substances 0.000 claims description 13
- 230000002401 inhibitory effect Effects 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 9
- 238000005349 anion exchange Methods 0.000 claims description 6
- 238000000502 dialysis Methods 0.000 claims description 6
- 239000002808 molecular sieve Substances 0.000 claims description 6
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 3
- 108091005804 Peptidases Proteins 0.000 claims description 2
- 102000035195 Peptidases Human genes 0.000 claims description 2
- 238000000862 absorption spectrum Methods 0.000 claims description 2
- 239000003471 mutagenic agent Substances 0.000 claims description 2
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 claims description 2
- 238000001179 sorption measurement Methods 0.000 claims description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 9
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 9
- 238000010828 elution Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 8
- 238000005979 thermal decomposition reaction Methods 0.000 description 8
- 235000010980 cellulose Nutrition 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 5
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 239000007995 HEPES buffer Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 229920000298 Cellophane Polymers 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 102000008015 Hemeproteins Human genes 0.000 description 2
- 108010089792 Hemeproteins Proteins 0.000 description 2
- 240000001462 Pleurotus ostreatus Species 0.000 description 2
- 235000001603 Pleurotus ostreatus Nutrition 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000001853 liver microsome Anatomy 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 102100021277 Beta-secretase 2 Human genes 0.000 description 1
- 101710150190 Beta-secretase 2 Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 239000012506 Sephacryl® Substances 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- YCSBALJAGZKWFF-UHFFFAOYSA-N anthracen-2-amine Chemical compound C1=CC=CC2=CC3=CC(N)=CC=C3C=C21 YCSBALJAGZKWFF-UHFFFAOYSA-N 0.000 description 1
- 238000001479 atomic absorption spectroscopy Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 210000001589 microsome Anatomy 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000732 tissue residue Toxicity 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Peptides Or Proteins (AREA)
Description
【発明の詳細な説明】
本発明は、キャベツジュース中より突然変異原性物質の
突然変異性を阻害する因子を分離精製する方法に関する
。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for separating and purifying factors that inhibit mutagenicity of mutagenic substances from cabbage juice.
Nーブチル−Nーアセトキシメチルニトロンアミン、ソ
ルビン酸と西硝酸との反応生成物、2ーアミノアントラ
セン、エチジウムブロマイド、トリプトフアンやオルニ
チン等のアミノ酸の加熱分解産物などが突然変異原性物
質であることは知られている。N-butyl-N-acetoxymethylnitrone amine, the reaction product of sorbic acid and Nishi-nitric acid, 2-aminoanthracene, ethidium bromide, and thermal decomposition products of amino acids such as tryptophan and ornithine are mutagenic substances. Are known.
従来自然界にもサルノコシカケ、ヒラタケ、シイタケ等
制ガン効果があるといわれるものがいくつかあり、この
ほかにも未知の制ガン作用を有するものがあると考えら
れる。In the natural world, there are a number of mushrooms that are said to have anticancer effects, such as oyster mushrooms, oyster mushrooms, and shiitake mushrooms, and it is thought that there are other things that have unknown anticancer effects.
本発明者らは、自然界から制ガン作用ある物質を探索す
る目的で研究を行なった結果、食生活の身近かなキャベ
ツにトリプトフアンの加熱分解産物の突然変異性を阻害
する因子が存在することを知った。As a result of conducting research to search for substances with anticancer effects from nature, the present inventors discovered that cabbage, which is a familiar part of the diet, contains a factor that inhibits the mutagenicity of the thermal decomposition products of tryptophan. Ta.
本発明により、前記の突然変異性阻害物質を分離精製す
るには、該阻害物質を含有するキャベツを水洗し、低温
例えば0℃に保ってジューサーにかけ、キャベツジュー
スとし、これを遠心して組織片を除去し、その上清をさ
らに超遠心して上清を採取し、該上蒲を陰イオン交換セ
ルロースと接触し、陰イオン交換セルロースに吸着しな
い画分について腸イオン交換セルロースに適用し、低塩
濃度で溶出する活性画分を採取し、場合により限外ロ過
を行った後該画分を分子ふるいに吸着することによって
達成される。According to the present invention, in order to separate and purify the above-mentioned mutagenic inhibitor, the cabbage containing the inhibitor is washed with water, kept at a low temperature, for example, 0°C, and run through a juicer to obtain cabbage juice, which is then centrifuged to extract tissue pieces. The supernatant was further ultracentrifuged to collect the supernatant, and the supernatant was contacted with anion exchange cellulose, and the fraction that did not adsorb to the anion exchange cellulose was applied to the intestinal ion exchange cellulose to obtain a low salt concentration. This is achieved by collecting the active fraction eluted in the water, optionally performing ultrafiltration, and then adsorbing the fraction onto a molecular sieve.
前記上蒲を超遠心する工程と、前記陰イオン交換セルロ
ースと接触する工程の間に、透析か、または分子ふるい
に吸着して吸着される低分子を除去する工程を含むこと
もできる。Between the step of ultracentrifuging the supernatant and the step of contacting with the anion exchange cellulose, a step of removing the adsorbed low molecules by dialysis or adsorption on a molecular sieve may be included.
また全工程を通じ、操作は5℃以下で行うのが好ましい
。透析は、例えばセロフアン膜を使用し、50mMのH
EPES(N−2ーヒドロキシエチルピベラジン−N′
−2−ェタンスルホン酸)またはリン酸緩衝液で行う。Further, throughout the entire process, the operation is preferably carried out at 5°C or lower. Dialysis is carried out using, for example, a cellophane membrane and 50mM H
EPES (N-2-hydroxyethylpiverazine-N'
-2-ethanesulfonic acid) or phosphate buffer.
また分子ふるいは、分子量1000以下の低分子を吸着
するものが選ばれる。使用し得る陰イオン交換セルロー
スとしては、DEAEーセルロース、TEAE−セルロ
ース、AE−セルロースがある。Further, as the molecular sieve, one that adsorbs low molecules having a molecular weight of 1000 or less is selected. Anion exchange celluloses that can be used include DEAE-cellulose, TEAE-cellulose, and AE-cellulose.
陽イオン交換セルロースとしては、CMC、Pーセルロ
ース、PPM−セルロースがある。Examples of cation exchange cellulose include CMC, P-cellulose, and PPM-cellulose.
最後の工程で使用し得る分子ふるいとしては、セフアク
リル、セフアデツクスG一7iバイオゲルP−30カギ
ある。(セフアクリル、セフアデツクスはスウェーデン
Pha肌acia社の、バィオゲルは米国Bio−Ra
d社の商品名である。以下同じ。)限外ロ過膜は、UM
−10、UM−2庇、PM−30等の分子量30000
以下の分子を透過する限外ロ過膜が使用できる。(UM
−10、UM−2皿、PM−30は米国Amicon社
の商品名である。以下同じ。)本発明方法によって得ら
れる突然変異性阻害因子は28加川および404nのに
特徴的な吸収スペクトルを有し、熱に安定でタンパク分
解酵素で失活する。これをドデシル硫酸ナトリウムーゲ
ル電気泳動法により測定すると、分子量約43000の
タンパク性物質である。該物質は、後記のヒスチジン要
求性サルモネラTA9玖珠のトリプトフアン熱分解産物
による突然変異試験において、突然変異を顕著に阻害し
た。該因子の構成アミノ酸のモルパーセントは次のとお
りである。Molecular sieves that can be used in the final step include Cephacryl and Cephadex G-7i Biogel P-30 Kagi. (Cefacryl and Cefadex are from Phahadacia in Sweden, and biogel is from Bio-Ra in the US.
This is the product name of company d. same as below. ) Ultrafiltration membrane is UM
-10, UM-2 eave, PM-30 etc. molecular weight 30000
Ultrafiltration membranes that are permeable to the following molecules can be used: (U.M.
-10, UM-2 plate, and PM-30 are trade names of Amicon, USA. same as below. ) The mutagenic inhibitory factor obtained by the method of the present invention has a characteristic absorption spectrum of 28 Kagawa and 404n, is stable to heat, and is inactivated by proteolytic enzymes. When measured by sodium dodecyl sulfate gel electrophoresis, it was found to be a proteinaceous substance with a molecular weight of about 43,000. This substance significantly inhibited mutation in the mutation test using tryptophan thermal decomposition products of histidine-requiring Salmonella TA9 Kusu described below. The mole percentages of the constituent amino acids of the factor are as follows.
Asp 1
3.22Thr
843Ser
6.70GIu
6.38Pro
6.56GIy
7.物AIa
9.89C$
1.73Va1
5.7
7Met l.
29lieu
3.44Leu
ll.64Tyr
l.31Phe
5.36Lys
2.59Hig
l.07Arg
7.40以下実
施例によって本発明方法をさらに詳細に説明する。Asp 1
3.22 Thr
843Ser
6.70GIu
6.38Pro
6.56GIy
7. thing AIa
9.89C$
1.73Va1
5.7
7Met l.
29lieu
3.44 Leu
ll. 64 Tyr
l. 31Phe
5.36Lys
2.59High
l. 07Arg
7.40 The method of the present invention will be explained in more detail with the following examples.
キャベツ1000〜2000夕を十分水洗し、0℃に保
ってジューサーにかけ、キャベツジュースを得た。1,000 to 2,000 pieces of cabbage were sufficiently washed with water, kept at 0°C, and run through a juicer to obtain cabbage juice.
このジュースを4℃において900ので30分間遠心し
、クロロプラスト、ミトコンドリア核等の組織残澄を除
去し、その上清を4℃にて20000的で2時間超遠心
し、ミクロソーム、リボンーム等を除去した。ここで得
られた528の‘の上情をセロフアン透析膜を用い、5
0mM HEPES緩衝液(pH6.8)にて透析した
。透析液は2回交換した。透析によって分子量約100
0以下の低分子化合物は除かれる。透析したキャベツジ
ュースは、次にDEAE−セルロースの力ラムクロマト
グラフイにかけた。カラムサィズは4×37肌で、流速
は122の【/時、溶出量は試験管当り15の【づつ採
取した。溶出液は50のM HEPES緩衝液(pH6
.8)中、塩化カリウム濃度が0〜500mMに段階的
に変化する溶液を使用した。溶出は4℃で行う。得られ
る各画分について28仇肌のタンパク吸収を調べたとこ
ろ、5つの分離ピークが認められた。これら各画分につ
いて、トリプトフアンの加熱分解物に対する阻害効果を
後述の試験方法で調べたところ、DEAEーセルロース
に吸着しない函分、すなわち塩化カリウム濃度0の画分
にのみ強い活性を認めた。この溶出曲線を第1図として
示す。このようにして強い阻害効果を認めた画分110
0Mで得られ、これをカルボキシメチルセルローズの力
ラムクロマトグラフイにかけた。カラムサイズは2.5
×8肌で、流速69叫/時、溶出量は試験管当り3の‘
づつ採取した。溶出緩衝液は、50mM HEPES緩
衝液120羽と、0〜0.8MKC1 120叫(Na
CIでもよい)とでKCIにつき濃度勾配を作成し、K
CI濃度を連続的に変化させて溶出した。This juice was centrifuged at 900°C for 30 minutes at 4°C to remove tissue residue such as chloroplasts and mitochondrial nuclei, and the supernatant was ultracentrifuged at 4°C and 20,000°C for 2 hours to remove microsomes, ribbon bands, etc. did. Using cellophane dialysis membrane, we applied 528' results obtained here.
Dialysis was performed against 0mM HEPES buffer (pH 6.8). The dialysate was exchanged twice. The molecular weight is approximately 100 by dialysis.
Low molecular weight compounds of 0 or less are excluded. The dialyzed cabbage juice was then subjected to DEAE-cellulose force ram chromatography. The column size was 4 x 37 cells, the flow rate was 122/hour, and the elution volume was 15/hour. The eluate was a 50 M HEPES buffer (pH 6).
.. 8), a solution in which the potassium chloride concentration was changed stepwise from 0 to 500 mM was used. Elution is performed at 4°C. When the protein absorption of each of the obtained fractions was examined in 28 skins, five separated peaks were observed. When each of these fractions was examined for its inhibitory effect on thermal decomposition products of tryptophan using the test method described below, strong activity was observed only in the fraction that did not adsorb to DEAE-cellulose, that is, the fraction with a potassium chloride concentration of 0. This elution curve is shown in FIG. Fraction 110, in which a strong inhibitory effect was observed
0M, which was subjected to force lamb chromatography on carboxymethyl cellulose. Column size is 2.5
x 8 tubes, flow rate 69 m/hr, elution volume 3' per test tube.
I took one by one. The elution buffer consisted of 50mM HEPES buffer and 120mM KC1 (Na
CI may be used) to create a concentration gradient for KCI, and K
Elution was performed by continuously changing the CI concentration.
操作はすべて4℃で実施した。得られた各画分について
28加川のタンパク吸収を調べたところ、4つの分離ピ
ークが認められた。これら各画分について、後述の試験
方法によって阻害効果を調べたところ、KCI濃度0.
09M‘こ最大溶出ピークを有する画分にその活性を認
めた。このKCIの低濃度で溶出される試験管7本分の
画分を集めたところ、21Mを得た。この熔出曲線を第
2図に示す。この高活性画分をUM−10フィル夕を用
いて限外o過し、さらに濃縮した。濃縮した画分2.0
の‘をセフアクリルS−200カラムにてさらに分離精
製を行った。カラムサイズは1×92肌、溶出液は50
mMトリス一日CI(pH8.0)緩衝液で、溶出速度
は試験管当り40滴づつ採集した。操作はすべて4℃で
行った。これら各画分について前述同様28仇肌のタン
パク吸収を調べたところ、大きく4つに分離ピークが認
められた。これら各画分について後述の試験法により阻
害効果を調べたところ、2番目の熔出した画分に強い阻
害活性が認められた。精製の各段階における精製度を知
るため、ローリー法で測定したタンパク量を基準とし、
50%変異阻害度の活性比を求めたところ、もとのキャ
ベツジュースを1とすれば、DEAEセルロース処理に
より約2倍、CMCカラムクロマトグラフィーにより約
20ぴ音、セフアクリルカラム処理により約45ぴ音活
性が高められていることがわかった。All operations were performed at 4°C. When the protein absorption of 28 Kagawa was examined for each of the obtained fractions, four separated peaks were observed. When the inhibitory effect of each of these fractions was examined using the test method described below, it was found that the KCI concentration was 0.
The activity was observed in the fraction having the maximum elution peak of 09M'. When the fractions from 7 test tubes eluted at this low concentration of KCI were collected, 21M was obtained. This melting curve is shown in FIG. This highly active fraction was subjected to ultraviolet filtration using a UM-10 filter and further concentrated. Concentrated fraction 2.0
was further separated and purified using a Sephacryl S-200 column. Column size is 1 x 92 skin, eluent is 50
The elution rate was 40 drops per tube in mM Tris 1 day CI (pH 8.0) buffer. All operations were performed at 4°C. When the protein absorption of each of these fractions was examined in the same manner as described above, four major separated peaks were observed. When the inhibitory effect of each of these fractions was examined using the test method described below, strong inhibitory activity was observed in the second molten fraction. In order to know the degree of purification at each stage of purification, the amount of protein measured by the Lowry method is used as the standard.
When the activity ratio of 50% mutation inhibition was determined, if the original cabbage juice was 1, DEAE cellulose treatment increased the activity ratio to about 2 times, CMC column chromatography increased it to about 20 pm, and CMC column treatment increased it to about 45 pm. It was found that the sound activity was increased.
このキャベツから分離精製した突然変異性阻害因子は、
loo。C9粉ごの加熱において50%が失活するに過
ぎないが、プロナーゼにより失活することが判明した。
ドデシル硫酸ナトリウム電気泳動法により、分子量約4
3000のタンパク性物質であることがわかった。該因
子は404nのに特徴的な吸収を有しているが、この吸
収はへムタンパクに特有なSoretbandを示すも
のであり、該因子は原子吸光分析により、タンパク量1
の2当り、鉄0.鼠2ムタ含有し、本因子の分子量43
000からタンパク1モル当り鉄は0.4班モルと計算
された。The mutagenic inhibitory factor isolated and purified from this cabbage is
loo. Although only 50% of C9 powder was inactivated by heating, it was found that pronase inactivated it.
Molecular weight approximately 4 by sodium dodecyl sulfate electrophoresis
It was found to be 3000 proteinaceous substances. This factor has a characteristic absorption of 404n, which shows the Soretband characteristic of heme proteins, and the factor has been determined by atomic absorption spectrometry to have a protein amount of 1.
per 2, iron 0. Molecular weight of this factor is 43.
000, iron content was calculated to be 0.4 mol per mol of protein.
また重亜硫酸ナトリウムを加えると該Soret舷nd
が436.則肌にシフトし、吸収強度が減少する等の現
象からして、酸化型(Fe3十)から還元型(Fe2十
)への変化によるものと認められることからへムタンパ
クの性質を有することが判明した。トリプトフアン加熱
分解産物に対する突然変異阻害効果試験:ジメチルスル
ホキシド0.02の‘に溶解したトリプトフアン熱分解
産物10〃のこ、前述の方法で分離した各画分0.5の
‘を加え、37q0で30分間反応させ、その後系中の
阻害因子をすべて不活性化するため100qoにて10
分間加熱処理する。Also, if sodium bisulfite is added, the Soret port
is 436. Based on phenomena such as a shift to normal skin and a decrease in absorption strength, it is recognized that this is due to a change from an oxidized type (Fe30) to a reduced type (Fe20), which indicates that it has the properties of heme protein. did. Mutation inhibition effect test on tryptophan thermal decomposition products: 10% of tryptophan thermal decomposition products dissolved in 0.02% of dimethyl sulfoxide, 0.5% of each fraction separated by the above method was added, and 30% of tryptophan was dissolved in 37q0 to inactivate all inhibitory factors in the system.
Heat for 1 minute.
加熱処理後、ソフトアガー(0.5%DjfcoA鞍r
、米国DiにoLaboratories社製)3の‘
を加え、サルモネラTA蛾(ヒスチジン要求性)の菌液
0.1肌を加える。これにSD系ラットより、PCBに
て酵素活性を高めた肝臓を摘出し、ホモジネートおよび
遠○して得られた肝ミクロソームと以下の組成からなる
緩衝液を加えたS−9ミックス0.3の‘を、以下の寒
天塔地へ流し、37o0で2日間培養し、ヒスチジン非
要求性の復帰変異コロニー数を教える。S−9に加えら
れる無機塩:肝ミクロソーム 3私
〇.28MNa2HP。After heat treatment, soft agar (0.5% DjfcoA saddle
(manufactured by oLaboratories, Inc., USA) 3'
and 0.1 skin of Salmonella TA moth (histidine auxotrophic) bacterial solution. To this, liver microsomes obtained by extracting the liver with increased enzyme activity using PCB from SD rats and homogenizing and centrifuging were added to S-9 mix 0.3 with a buffer consisting of the following composition. ' was poured onto the agar plate shown below, cultured at 37o0 for 2 days, and the number of histidine-independent revertant colonies was determined. Inorganic salts added to S-9: Liver microsomes 3 I〇. 28MNa2HP.
4 4の‘〇.laMMgC
12 0.5の‘0.68
MKCI O‐5凧【〇
.〇8M G一6一p l.〇泌
〇.〇山MNADP I.〇
のZ選択用寒天塔地:MN(X20)
50の【40%グルコース
10叫D的o NuUient Brotho.8
%(米国DifcoLaboratories社製)
10の【ビオチン(10比′泌)
1m【アガー
15夕蒸留水 930叫M
N(×20)の組成:(N比)2S04
2.0%KH2P04
20.0%MgS04・7日20
0.2%クエン酸ナトリウム
1.0%KOHにてpH7.0に調節阻害効果は
、キャベツジュース処理をしない突然変異原物質である
トリプトフアンの加熱分解産物の復起変異コロニー数が
300〜40の固であり、これと比較してキャベツジュ
ースで処理したトリプトフアン加熱分解産物の復帰コロ
ニー数を計数し、復帰コロニー数がどの程度減少するか
を調べた。4 4'〇. laMMgC
12 0.5'0.68
MKCI O-5 kite [〇. 〇8M G-61p l. 〇Secretion〇. 〇Yama MNADP I. Agar base for Z selection of 〇: MN (X20)
50 [40% glucose
10 shouts D o NuUient Brotho. 8
% (manufactured by Difco Laboratories, USA)
10 [biotin (10 ratio' secretion)
1m [Agar
15th evening distilled water 930m
Composition of N (×20): (N ratio) 2S04
2.0%KH2P04
20.0%MgS04・7days 20
0.2% sodium citrate
The effect of inhibiting regulation at pH 7.0 with 1.0% KOH is that the number of re-mutated colonies of the thermal decomposition product of tryptophan, a mutagen, without cabbage juice treatment is 300 to 40, compared with this. The number of returning colonies of tryptophan thermal decomposition products treated with cabbage juice was counted, and the extent to which the number of returning colonies decreased was investigated.
第1図はDEAE−セルロースカラムクロマトグラフィ
における溶出曲線図、第2図はCMC力ラムクロマトグ
ラフィにおける溶出曲線図である。
図一
蝦
図
N
幸船FIG. 1 is an elution curve diagram in DEAE-cellulose column chromatography, and FIG. 2 is an elution curve diagram in CMC column chromatography. Figure 1 Shrimp Figure N Sachifune
Claims (1)
因子を含むキヤベツジユースを遠心する工程その上清を
超遠心する工程、その上清を陰イオン交換セルロースと
接触する工程、陰イオン交換セルロースに吸着しない画
分に陽イオン交換セルロースに適用する工程、低塩濃度
で溶出する活性画分を採取する工程、該画分をさらに分
子ふるいに吸着して精製する工程とを含むことを特徴と
する280nmおよび404nmに特徴的な吸収スペク
トルを有し、熱に安定でタンパク分解酵素で失活する前
記の突然変異性阻害因子を分離精製する方法。 2 前記上清を超遠心する工程と前記陰イオン交換セル
ロースと接触する工程との間に、透析を行うか、または
分子ふるいに吸着して吸着される低分子を除去する工程
を含む特許請求の範囲第1項の方法。 3 全工程を5℃以下の温度で行う特許請求の範囲第1
項または第2項の方法。[Scope of Claims] 1. A step of centrifuging a cartridge containing a factor that inhibits the mutagenicity of a mutagenic substance. A step of ultracentrifuging the supernatant. A step of contacting the supernatant with anion exchange cellulose. a step of applying cation-exchanged cellulose to the fraction that does not adsorb to anion-exchanged cellulose, a step of collecting an active fraction eluting at a low salt concentration, and a step of further adsorbing the fraction to a molecular sieve to purify it. A method for isolating and purifying the mutagenic inhibitory factor as described above, which has a characteristic absorption spectrum at 280 nm and 404 nm, is stable to heat, and is inactivated by proteolytic enzymes. 2. Between the step of ultracentrifuging the supernatant and the step of contacting the supernatant with the anion exchange cellulose, the claim includes a step of performing dialysis or removing adsorbed low molecules by adsorption to a molecular sieve. Method of scope 1. 3 Claim 1 in which the entire process is carried out at a temperature of 5°C or less
Section or method of Section 2.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP53028840A JPS603287B2 (en) | 1978-03-14 | 1978-03-14 | Method for isolating and purifying factors that inhibit mutagenicity of mutagenic substances from cabbage use |
| US05/940,089 US4191752A (en) | 1978-03-09 | 1978-09-06 | Isolation of anti-mutagenic factor from cabbage juice |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP53028840A JPS603287B2 (en) | 1978-03-14 | 1978-03-14 | Method for isolating and purifying factors that inhibit mutagenicity of mutagenic substances from cabbage use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS54122715A JPS54122715A (en) | 1979-09-22 |
| JPS603287B2 true JPS603287B2 (en) | 1985-01-26 |
Family
ID=12259555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53028840A Expired JPS603287B2 (en) | 1978-03-09 | 1978-03-14 | Method for isolating and purifying factors that inhibit mutagenicity of mutagenic substances from cabbage use |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS603287B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5942657B2 (en) * | 1979-11-26 | 1984-10-16 | カネボウ株式会社 | Method for separating and purifying anionic polymer electrolytes from burdock juice |
| JP2000041624A (en) * | 1998-08-04 | 2000-02-15 | Koba Kazuaki | Dried food of cabbage juice and cooking of fish utilizing the same |
-
1978
- 1978-03-14 JP JP53028840A patent/JPS603287B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS54122715A (en) | 1979-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rosenberg et al. | Fractionation of the protein components of human erythrocyte membranes | |
| JP2553180B2 (en) | Extraction method of pure fractions of lactoperoxidase and lactoferrin from whey | |
| US4191752A (en) | Isolation of anti-mutagenic factor from cabbage juice | |
| AU592837B2 (en) | A process for the specific separation of lactose from milk | |
| JP3438735B2 (en) | Method for isolating human albumin from supernatant IV, especially IV-4 or corn fraction V or a similar supernatant or fraction | |
| CN105017412A (en) | Method for separating high-purity bovine serum albumin from bovine serum | |
| HU219828B (en) | Method for Isolation and Purification of Vitamin K Dependent Proteins | |
| JPS58219124A (en) | Preparation of multiplicative factor of human epithelial cell | |
| JPS603287B2 (en) | Method for isolating and purifying factors that inhibit mutagenicity of mutagenic substances from cabbage use | |
| JPH03502200A (en) | Method for producing highly purified non-infectious anti-hemophilic factors by chromatography | |
| JP3745805B2 (en) | Purification method of thrombomodulin | |
| CN107033237B (en) | Separation and purification method of human plasma apolipoprotein A-I | |
| WO1981001517A1 (en) | Process for isolating and purifying a fraction capable of inhibiting mutagenicity of a mutagenic material from burdock juice | |
| SU513595A3 (en) | The method of selection orgoteina | |
| WO2002008249A1 (en) | Method of purifying calcium ion-binding protein | |
| JPS6251589B2 (en) | ||
| Strøbæk et al. | Ribulose-1, 5-diphosphate carboxylase from barley (Hordeum vulgare) Isolation, characterization, and peptide mapping studies of the subunits | |
| WO1982002834A1 (en) | Process for recovering interferon | |
| SU1108102A1 (en) | Method of obtaining peroxidase | |
| Kan et al. | Application of aqueous two-phase system in separation/purification of stroma free hemoglobin from animal blood | |
| Kasinsky et al. | Chromatographic separation of horseradish peroxidase isozymes from commercial preparations | |
| RU2042358C1 (en) | Method of preparing factor ix concentrate | |
| JPS641117B2 (en) | ||
| JPH08176199A (en) | Method for purifying hirudine by affinity chromatography | |
| JPS6210968B2 (en) |